MedTrace Logo

Topical 5% Minoxidil and Potent Topical Corticosteroid Versus Intralesional Corticosteroid in the Treatment of Alopecia Areata

NCT03535233 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2018-05-24

No results posted yet for this study

Summary

Alopecia areata (AA) presents with circumscribed patches of non-scarring hair loss. It inflects a significant psychological and social burden. Many treatment options are used for the treatment of AA. Randomized controlled trials comparing intralesional and topical therapy and comparing combinations are few.

The aim of this work is to evaluate the efficacy of combined topical 5% minoxidil and potent topical corticosteroid therapy compared to intralesional triamcinolone injection in alopecia areata

Conditions

Interventions

DRUG

Triamcinolone Acetonide

DRUG

Minoxidil 5 % Topical Spray

DRUG

clobetasol propionate

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Nermine H El-Eishi, MD · Cairo University

  • Heba M Mashaly, MD · Cairo University

  • Solwan I El-Samanoudy, MD · Cairo University

  • Mona MI ElKalioby, MD · Cairo University

  • Olfat G Shaker, MD · Cairo University

  • Rania M Abdel-Hay, MD · Cairo University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-03-31
Primary Completion
2017-06-30
Completion
2017-09-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03535233 on ClinicalTrials.gov